Please make JavaScript on and see this site.
December 13, 2024
Review
New
Check List for 30-day-Clinical Trial Notification Review on an Initial Clinical Trial Notification (Oncology Drugs)
December 13, 2024
Other
New
Recent Publications by PMDA Staff updated
December 11, 2024
Safety
New
MHLW Pharmaceuticals and Medical Devices Safety Information No.415 posted
December 11, 2024
Review
New
English Translation of Review Report: Ezharmia (Partial Change Approval)
December 9, 2024
Pub cmt
New
JP Drafts (December 2024) posted
December 6, 2024
Int
Seminar schedule has been updated
December 5, 2024
Safety
Notifications on Self-Inspection (In Vitro Diagnostics):Self-Inspection of Package Inserts for In Vitro Diagnostics for Detection of Influenza Viruses posted
December 5, 2024
Review
List of Approved Products (New Drugs): April 2004 to September 2024
December 5, 2024
Int
GMP class has been added to the Pharmaceuticals Review of E-learning Courses.
December 2, 2024
Review
English translation of review report: Toraymyxin
December 13, 2024
New
Check List for 30-day-Clinical Trial Notification Review on an Initial Clinical Trial Notification (Oncology Drugs)
December 11, 2024
Drug
New
English Translation of Review Report: Ezharmia (Partial Change Approval)
December 5, 2024
Drug
List of Approved Products (New Drugs): April 2004 to September 2024
December 2, 2024
Devices
English translation of review report: Toraymyxin
Currently, there is no applicable information.